Treatment of perioperative hypertension

Anesthesiology Clinics of North America

Volumn 17, Issue 3, 1999, Pages 567-579

  Levy, J H ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CLEVIDIPINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; ENALAPRILAT; FELODIPINE; FENOLDOPAM; FENOLDOPAM MESILATE; IRBESARTAN; ISRADIPINE; LOSARTAN; NICARDIPINE; NIFEDIPINE; NITRATE; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG; VASODILATOR AGENT; VERAPAMIL;

BRAIN ISCHEMIA; CARDIOTOXICITY; CARDIOVASCULAR RISK; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; HUMAN; HYPERTENSION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PERIOPERATIVE PERIOD; REVIEW; SUBLINGUAL DRUG ADMINISTRATION; SURGICAL RISK;

EID: 0032833044     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8537(05)70118-8     Document Type: Article

References (122)

1. G. Abraham A. Shukkur J. Van Der Meulen Sublingual nifedipine—a safe and simple therapy for hypertensive emergencies Br J Clin Pract 40 1986 478 481
2. V.P. Addonizio J.B. Smith J.F. Strauss Thromboxane synthesis and platelet secretion during cardiopulmonary bypass with bubble oxygenator J Thorac Cardiovasc Surg 79 1980 91 96
3. A.G. Adler J.J. Leahy M.D. Cressman Management of perioperative hypertension using sublingual nifedipine: Experience in elderly patients undergoing eye surgery Arch Intern Med 146 1986 1927 1930
4. P. Angeli M. Chiesa L. Caregaro Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies: A randomized, single-blind clinical trial Arch Intern Med 151 1991 678 682
5. I. Apostolidou G.J. Despotis C. McCowley Anti-ischemic effects of intravenous nicardipine and nitroglycerine following CABG surgery Anaesth Analg 82 1996 SCA43
6. S. Aronson L.I. Goldberg D. Glock Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia J Cardiothorac Vasc Anesth 5 1991 29 32
7. D.R. Bailey E.D. Miller J.A. Kaplan The renin-angiotensin-aldosterone system during cardiac surgery with morphine-nitrous oxide anesthesia Anesthesiology 42 1975 538 544
8. G.H. Barbier U.R. Shettigard D.O. Appun Clinical rationale use of an ultra-short acting beta-blocker: Esmolol J Clin Pharmacol Ther 33 1995 212 218
9. J.H. Bauer G.P. Reams The role of calcium entry blockers in hypertensive emergencies Circulation 75 6, pt2 1987 174 180
10. L.C. Becker Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia Circulation 57 1978 1103 1110
11. N. Beer I. Gallegos A. Cohen Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension Chest 79 1981 571 574
12. G. Bonner S. Preis U. Schunk Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans J Cardiovasc Pharmacol 15 1990 S46 S56
13. H. Bouaziz Y. Joulin M. Safar Effects of bradykinin B (2) receptor antagonism on the hypotensive effects of ACE inhibition Br J Pharmacol 113 1994 717 722
14. N.W. Brister R.E. Barnette S.A. Schartel Isradipine for treatment of acute hypertension after myocardial revascularization Crit Care Med 19 1991 334 338
15. N.J. Brown W.A. Ray M.R. Griffin Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema Clin Pharmacol Ther 60 1996 8 13
16. N.J. Brown D. Ryder J.V. Gainer Differential effects of ACE inhibitors on the vasodepressor and prostacyclin responses to bradykinin J Pharmacol Exp Ther 279 1996 703 712
17. N.J. Brown D.E. Vaughan Angiotensin-converting enzyme inhibitors Circulation 97 1998 1411 1420
18. J.F. Buris E.D. Freis Hypertensive emergencies Messerli F.H. Cardiovascular Drug Therapy 1996 WB Saunders Philadelphia
19. M.A. Cascieri H.G. Bull R.A. Mumford Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422 Mol Pharmacol 25 1984 287 293
20. E.S. Casella T.T.J. Blanck Verapamil infusion for lowering blood pressure cardiopulmonary bypass J Cardiovasc Pharmacol 12 suppl 6 1988 S172
21. M. Chiarello H.K. Gold R.C. Leinbach Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction Circulation 54 1976 766
22. E. Cook G.G. Clifton R. Vargas Pharmacokinetics, pharmacodynamics and minimum effect of clinical dose of nicardipine Clin Pharmacol Ther 47 1990 706 718
23. V.N. Dadkar N.D. Karnik M. Izar Sublingual nifedipine and captopril in hypertensive urgencies and emergencies Ind Heart J 45 1993 185 187
24. A.H. Danser J.P. van Kats P.J. Admiraal Cardiac renin and angiotensins: Uptake from plasma versus in situ synthesis Hypertension 24 1994 37 48
25. D. David C. Dubois Y. Loria Comparison of nicardipine and sodium nitroprusside in the treatment of paroxysmal hypertension following aortocoronary bypass surgery J Cardiothorac Vasc Anesth 5 1991 357 361
26. M.E. Davis C.J.H. Jones R.O. Feneck Intravenous nifedipine for control of hypertension in patients after coronary artery bypass graft surgery J Cardiothorac Anesth 2 1988 130 139
27. G.F. DiBona M. Epstein J. Mann Renal protection aspects of calcium antagonists Kidney Int 41 1992 1 118
28. D.E. Dostal G.W. Booz K.M. Baker Angiotensin II signalling pathways in cardiac fibroblasts: Conventional versus novel mechanisms in mediating cardiac growth and function Mol Cell Biochem 157 1996 15 21
29. M.A. Durkin D. Thys R.B. Morris Control of perioperative hypertension during coronary artery surgery: A randomized double-blind study comparing isosorbide dinitrate and nitroglycerin Eur Heart J 9 suppl A 1988 181 185
30. V.J. Dzau Renal effects of angiotensin-converting enzyme inhibition in cardiac failure Am J Kidney Dis 10 1987 74 80
31. V.J. Dzau Vascular renin-angiotensin system and vascular protection J Cardiovasc Pharmacol 22 suppl 1993 S1 S9
32. A.G. Ellrodt M.J. Ault M.S. Riedinger Efficacy and safety of sublingual nifedipine in hypertensive emergencies Am J Med 79 1985 19 25
33. R.M. Engleman H.R. Loannis R.H. Breyer Rebound vasospasm after coronary revascularization in association with calcium antagonist withdrawal Ann Thorac Surg 37 1984 469 472
34. R. Erbel G. Brand J. Meyer Emergency treatment of hypertensive crisis with sublingual nifedipine Postgrad Med J 59 suppl 3 1983 134 136
35. E.G. Erdos The angiotensin I converting enzyme Fed Proc 36 1977 1760 1765
36. Ericsson H, Höglund L, Nordlander M, et al: The pharmacokinetics of clevidipine, an ultra-short acting calcium antagonist, during constant infusion in healthy volunteers. Clin Pharmacol Ther 1997 (in press)
37. F.G. Estafanous R.C. Tarazi J.F. Viljoen Systemic hypertension following myocardial revascularization Am Heart J 85 1973 732 738
38. T.C. Fagan Acute reduction of blood pressure in asymptomatic patients with severe hypertension: An idea whose time has come—and gone Arch Intern Med 149 1989 2169 2170
39. J.T. Flaherty P.A. Magee T.L. Gardner Comparison of intravenous nitroglycerin and sodium nitroprusside for treatment of acute hypertension developing after coronary artery bypass surgery Circulation 65 1982 1072 1077
40. B. Folkow B. Johansson S. Mellander The comparative effects of angiotensin and noradrenaline on consecutive vascular sections Acta Physiol Scand 53 1961 99 104
41. F.M. Fouad F.G. Estafanous R.G. Tarazi Hemodynamics of postmyocardial revascularization hypertension Am J Cardiol 41 1978 564 569
42. S.E. Fremes R.D. Weisel R.J. Baird Effect of postoperative hypertension and its treatment J Thorac Cardiovasc Surg 86 1983 47 56
43. S.E. Fremes R.D. Weisele D.A. Mickle A comparison of nitroglycerin and nitroprusside: I. Treatment of postoperative hypertension Ann Thorac Surg 39 1985 53 60
44. J.A. Friederich J.F. Butterworth Sodium nitroprusside: Twenty years and counting Anesth Analg 81 1995 152 162
45. I.S. Gambhir S.S. Gupta D.S. Singh Sublingual nifedipine in hypertensive emergencies with special reference to cerebrovascular accident J Ind Med Assoc 89 1991 231 234
46. R.W. Gifford Jr Management of hypertensive crises JAMA 266 1991 829 835
47. J.L. Glock W.J. Morales Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: A randomized study Am J Obstet Gynecol 169 1993 960 964
48. M.E. Goldberg J. Cantillo M.S. Nemiroff Fenoldopam infusion for treatment of postoperative hypertension J Clin Anesth 5 5 1993 86 391
49. V.M. Gonzalez-Carmona C. Ibarra-Perez C. Jerjes-Sanchez Single-dose sublingual nifedipine as the only treatment in hypertensive urgencies and emergencies Angiology 42 1991 908 913
50. E. Grossman S. Bren F. Messerli Isradipine Messerli F.H. Cardiovascular Drug Therapy 1990 WB Saunders Philadelphia 1016 1024
51. E. Grossman F.H. Messerli T. Grodzicki Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 276 1996 1328 1331
52. D.G. Harrison J.N. Bates The nitrovasodilators: New ideas about old drugs Circulation 87 1993 1461 1467
53. D. Hasdai Sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies Arch Intern Med 152 1992 1725 1726
54. G.-W. He F.L. Rosenfeldt B.F. Buxton Reactivity of human isoflated internal mammary artery to constrictor and dilator agents: Implications for treatment of internal mammary artery spasm Circulation 80 1989 I-141 I-150
55. W. Hess V. Schulte-Sasse J. Tarnow Nifedipine versus nitroprusside for controlling hypertensive episodes during coronary artery bypass surgery Eur Heart J 5 1984 140 145
56. A.J. Hill R.O. Feneck R.K. Walesby A comparison of fenoldopam and nitroprusside in the control of hypertension following coronary artery surgery J Cardiothorac Vasc Anesth 7 1993 279 284
57. P.F. Hoar J.G. Stone A.N. Faltas Hemodynamic and adrenergic responses to anesthesia and operation for myocardial revascularization J Thorac Cardiovasc Surg 80 1980 242 248
58. P.P. Hoar R.F. Hickey D.J. Ullyot Systemic hypertension following myocardial revascularization: A method of treatment using epidural anesthesia J Thorac Cardiovasc Surg 71 1976 859 864
59. F.J. Hock K. Wirth U. Albus Hoe 140 a new potent and long acting bradykinin antagonist: In vitro studies Br J Pharmacol 102 1991 769 773
60. B. Hornig C. Kohler H. Drexler Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans Circulation 95 1997 1115 1118
61. M.C. Houston Treatment of hypertensive urgencies and emergencies with nifedipine Am Heart J 111 1986 963 969
62. D.E. Hricik P.J. Browning R. Kopelman Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney N Engl J Med 308 1983 373 376
63. W.R. Huckle H.S. Earp Regulation of cell proliferation and growth by angiotensin II Prog Growth Factor Res 5 1994 177 194
64. Z.H. Israili W.D. Hall Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy Ann Intern Med 117 1992 234 242
65. T.N. James G.R. Hageman F. Urthaler Anatomic and physiologic considerations of a cardiogenic hypertensive reflex Am J Cardiol 44 1979 852 859
66. P.R. Kastner J.E. Hall A.C. Guyton Control of glomerular filtration rate: Role of intrarenally formed angiotensin II Am J Physiol 246 1984 F897 F906
67. V. Kon A. Fogo I. Ichikawa Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition Kidney Int 44 1993 545 550
68. N. Kumar Y.K. Batra I. Bala Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancy-induced hypertension Can J Anaesth 40 1993 329 333
69. C.J. Lawrence A. Lestrade E. Chan Comparative study of isradipine and sodium nitroprusside in the control of hypertension in patients following coronary artery-bypass surgery Acta Anesthesiol Scand 37 suppl 99 1993 53 55
70. C.J. Lawrence A. Lestrade S. DeLange Isradipine, a calcium antagonist, in the control of hypertension following coronary artery-bypass surgery Am J Hypertens 4 1991 207S 209S
71. J.B. Leslie Incidence and aetiology of perioperative hypertension Acta Anesthesiol Scand 37 suppl 99 1993 5 9
72. J. Leslie N.W. Brister J.H. Levy Treatment of post operative hypertension following coronary artery bypass surgery: Double-blind comparison of intravenous isradipine and sodium nitroprusside Circulation 90 1994 256 261
73. J.H. Levy The ideal agent for perioperative hypertension Acta Anesthesiol Scand 37 suppl 99 1993 20 25
74. W. Linz B.A. Scholkens A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril Br J Pharmacol 105 1992 771 772
75. B. Ljung Vascular selectivity of felodipine Drugs 29 1985 46 58
76. G. LoCicero P. Binaghi G. Cellina Sublingual nifedipine—a new approach to the therapy of hypertensive crisis in pregnancy Minerva Ginecol 38 1986 631 635
77. B.R. Lucchesi Role of calcium on excitation contraction in cardiac and vascular smooth muscle Circulation 80 1989 IV-13
78. F.H. Messerli P. Kowey T. Grodzicki Sublingual nifedipine for hypertensive emergencies Lancet 338 1991 881
79. F.H. Messerli M.A. Weber H.R. Brunner Angiotensin II receptor inhibition: A new therapeutic principle Arch Intern Med 156 1996 1957 1965
80. J.C. Mullen D.R. Miller R.D. Weisel Postoperative hypertension: A comparison of diltiazem, nifedipine and nitroprusside J Thorac Cardiovasc Surg 96 1988 122 132
81. B.F. Murphy J.A. Whitworth P. Kincaid-Smith Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics Br Med J Clin Res 288 1984 844 845
82. A.P. Niarchos A.J. Roberts D.B. Case Hemodynamic characteristics of hypertension after coronary bypass surgery and effects of converting enzyme inhibitor Am J Cardiol 43 1979 586 593
83. M. Nordlander T. Abrahamsson B. Akerblom Vascular versus myocardial selectivity of dihydropyridine calcium antagonists as studied in vivo and in vitro Pharmacol Tox 75 1995 56 62
84. M. Nordlander J.-A. Björkman C.-G. Regardh Pharmacokinetic and hemodynamic effects of an ultra-short acting calcium antagonist Br J Anaesth 76 1996 12
85. K. Omata K. Abe K. Tsunoda Role of endogenous angiotensin II and prostaglandins in the antihypertensive mechanism of angiotensin converting enzyme inhibitor in hypertension Clin Exp Hypertens A9 1987 569 574
86. L.H. Opie Sublingual nifedipine Lancet 338 1991 1203
87. Os I, Bratland B, Dahlof B, et al: Female sex as an important determinant of lisinopril-induced cough [letter]. Lancet 339(8789):372
88. P.L. Padfield J.J. Morton Effects of angiotensin II on arginine-vasopressin in physiological and pathological situations in man J Clin Endocrinol 74 1977 251 259
89. A. Panacek E.M. Bednarczyk L.M. Dunbar Randomized, prospective trial of fenoldopam versus sodium nitroprussiate in the treatment of acute severe hypertension Acad Emerg Med 2 1995 959 965
90. F. Perez-Vizcaino J. Tamargo R.P. Hof Vascular selectivity of seven prototype calcium antagonists: A study at the single cell level J Cardiovasc Pharmacol 22 1993 768 775
91. D. Proud A.P. Kaplan Kinin formation: Mechanisms and role in inflammatory disorders Annu Rev Immunol 6 1988 49 83
92. P.G. Pryde S.B. Sedman C.E. Nugent Angiotensin-converting enzyme inhibitor fetopathy J Am Soc Nephrol 3 1993 1575 1582
93. D. Regoli J. Barabe Pharmacology of bradykinin and related kinins Pharmacol Rev 32 1980 1 46
94. A.J. Roberts A.P. Niarchos V.A. Subramanian Systemic hypertension associated with coronary artery bypass surgery: Predisposing factors, hemodynamic characteristics, humoral profile, and treatment J Thorac Cardiovasc Surg 74 1977 846 859
95. D.K. Rose M.M. Cohen D.e. Boer Cardiovascular events in the postanesthesia care unit, contribution of risk factors Anesthesiology 84 1996 772 781
96. P.C. Ruegg U. Karmann H. Keller Management of perioperative hypertension using intravenous isradipine Am J Hypertens 4 1991 203S 206S
97. A. Schwarz E. McKenna P.L. Vaghy Receptors for calcium antagonists Am J Cardiol 62 1988 3G 6G
98. A.B. Sedman D.B. Kershaw T.E. Bunchman Recognition and management of angiotensin converting enzyme inhibitor fetopathy Pediatr Nephrol 9 1995 382 385
99. D.M. Shoback G.H. Williams S.L. Swartz Time course and effect of sodium intake on vascular and hormonal responses to enalapril (MK 421) in normal subjects Cardiovasc Pharmacol 5 1983 1010 1018
100. A.I. Sintetos J. Hulse E.L.C. Pritchett Pharmacokinetics and pharmacodynamics of esmolol administrated as an intravenous bolus Clin Pharmacol Ther 41 1987 112
101. E.E. Slater D.D. Merrill H.A. Guess Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition JAMA 260 1988 967 970
102. J. Sun D.J. Triggle Calcium channel antagonists: Cardiovascular selectivity of action J Pharmacol Exp Ther 274 1995 419 426
103. S. Swartz G. Williams N. Hollenberg Captopril-induced changes in prostaglandin production J Clin Invest 65 1980 1257 1264
104. S. Tanaka K. Shimamoto T. Ando Role of renin angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril Clin Exp Hypertens A9 1987 605 609
105. K.M. Taylor I.J. Morton J.J. Brown Hypertension and the renin-angiotensin system following open-heart surgery J Thorac Cardiovasc Surg 74 1977 840 845
106. 2 during coronary revascularization J Thorac Cardiovasc Surg 93 1987 120 126
107. P.B. Timmermans P.C. Wong A.T. Chiu Angiotensin II receptors and angiotensin II receptor antagonists Pharm Rev 45 1993 205 251
108. M.A. Tobias Comparison of nitroprusside and nitroglycerin for controlling hypertension during coronary artery surgery Br J Anaesth 53 1981 891 897
109. D.J. Triggle Calcium channel drugs: Structure-function relationships and selectivity of action J Cardiovasc Pharmacol 18 1991 S1 S6
110. S.M. Underwood S.W. Davies R.O. Feneck Comparison of isradipine with nitroprusside for control of blood pressure following myocardial revascularization hypertension: Effects on hemodynamics, cardiac metabolism, and coronary blood flow J Cardiothorac Vasc Anesth 5 1991 348 356
111. P.J.A. Van der Starre J.E. Harnick-de Weerd R.S. Reneman Nitroprusside and ketanserine in the treatment of postoperative hypertension following coronary artery bypass grafting: A haemodynamic and ventilatory comparison J Hypertens 4 suppl 1 1986 S107 S110
112. P.M. Vanhoutte Endothelium and control of vascular function: State of the art lecture Hypertension 13 1989 658 667
113. H.B. VanWezel J.J. Koolen C.A. Visser Antihypertensive and anti-ischemic effects of nicardipine and nitroprusside in patients undergoing coronary artery bypass grafting Am J Cardiol 64 1989 22H 27H
114. R.J. Vecht K.T. Swanson E.P. Nicolaides Comparison of intravenous nicardipine and nitroglycerine to control systemic hypertension after coronary artery bypass grafting Am J Cardiol 64 1989 19H 21H
115. J.F. Viljoen F.G. Estafanous R.C. Tarazi Acute hypertension immediately after coronary artery surgery J Thorac Cardiovasc Surg 71 1976 548 550
116. L.E. Visser B.H. Stricker J. van der Velden Angiotensin converting enzyme inhibitor associated cough: A population-based case-control study J Clin Epidemiol 48 1995 851 857
117. R. Wallach R.B. Karp J.G. Reves Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: A study of hemodynamic and humoral factors Am J Cardiol 46 1980 559 565
118. R.R. Weber C.E. McCoy J.A. Fremiak Pharmacokinetics and pharmacodynamics of intravenous fenoldopam, a dopamine-1 receptor agonist in hypertensive patients Br J Clin Pharmacol 25 1988 17 22
119. K. Wirth F.J. Hock U. Albus Hoe 140 a new potent and long acting bradykinin antagonist: In vivo studies Br J Pharmacol 102 1991 774 777
120. K.S. Woo M.G. Nicholls High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese Br J Clin Pharmacol 40 2 1995 141 144
121. S.G. Wu S.L. Lin W.Y. Shiao Comparison of sublingual captopril, nifedipine and prazosin in hypertensive emergencies during hemodialysis Nephron 65 1993 284 287
122. B.G. Zimmerman E.J. Sybertz P.C. Wong Interaction between sympathetic and renin-angiotensin system J Hypertens 2 1984 581 587